Efficacy of Lanreotide for management of patients with chronic small bowel obstruction receiving palliative home Parenteral Nutrition and patients with non-malignant chronic small bowel obstruction receiving home parenteral nutrition

We report our experience of Lanreotide in the management of high output stoma (HOS), abdominal pain, nausea and vomiting in the setting of chronic small bowel obstruction (SBO) of malignant and non-malignant origin in patients receiving home parenteral nutrition (HPN).
Source: Clinical Nutrition ESPEN - Category: Nutrition Authors: Source Type: research